Publikationsliste PD Dr. med. Eva Christina Schwaneck
Clonal T cell populations scarcely impair patients with rheumatic diseases: a prospective long-term follow up study
Gernert M, Müller T, Schweiker L, Schmalzing M, Fröhlich M, Nagler LK, Strunz PP, Labinsky H, Schwaneck EC
Arthritis Res Ther. 2024 Dec 11;26(1):210. doi: 10.1186/s13075-024-03444-0. PMID: 39663523; PMCID: PMC11633000
Vaccination status of patients with primary immunodeficiencies in Germany-a multicentric epidemiologic analysis
Schwaneck EC, Harasim AS, Tony HP, Gawlik M, Witte T, Joos S, Gernert M, Schmalzing M, Morbach H, Fröhlich M, Krone M
Z Rheumatol. 2024 Aug 22. English. doi: 10.1007/s00393-024-01549-0. Epub ahead of print. PMID: 39174715.
Intestinal B cells license metabolic T-cell activation in NASH microbiota/antigen-independently and contribute to fibrosis by IgA-FcR signalling
Kotsiliti E, Leone V, Schuehle S, Govaere O, Li H, Wolf MJ, Horvatic H, Bierwirth S, Hundertmark J, Inverso D, Zizmare L, Sarusi-Portuguez A, Gupta R, O’Connor T, Giannou AD, Shiri AM, Schlesinger Y, Beccaria MG, Rennert C, Pfister D, Öllinger R, Gadjalova I, Ramadori P, Rahbari M, Rahbari N, Healy ME, Fernández-Vaquero M, Yahoo N, Janzen J, Singh I, Fan C, Liu X, Rau M, Feuchtenberger M, Schwaneck E, Wallace SJ, Cockell S, Wilson-Kanamori J, Ramachandran P, Kho C, Kendall TJ, Leblond AL, Keppler SJ, Bielecki P, Steiger K, Hofmann M, Rippe K, Zitzelsberger H, Weber A, Malek N, Luedde T, Vucur M, Augustin HG, Flavell R, Parnas O, Rad R, Pabst O, Henderson NC, Huber S, Macpherson A, Knolle P, Claassen M, Geier A, Trautwein C, Unger K, Elinav E, Waisman A, Abdullah Z, Haller D, Tacke F, Anstee QM, Heikenwalder M
J Hepatol. 2023 Aug;79(2):296-313. doi: 10.1016/j.jhep.2023.04.037. Epub 2023 May 22. PMID: 37224925; PMCID: PMC10360918
Patient-reported outcomes provide evidence for increased depressive symptoms and increased mental impairment in giant cell arteritis
Froehlich M, Zahner A, Schmalzing M, Gernert M, Strunz PP, Hueper S, Portegys J, Schwaneck EC, Gadeholt O, Kübler A, Hewig J, Ziebell P
Front Med (Lausanne). 2023 May 12;10:1146815. doi: 10.3389/fmed.2023.1146815. eCollection 2023.
Apps in der Rheumatologie: Bedarf es einer App in der Therapie der axialen Spondyloarthritis?
Strunz PP, Maire ML, Heusinger T, Hammel L, Gernert M, Schwaneck EC, Callhoff J, Portegys J, Schmalzing M, Tony HP, Froehlich M
Z Rheumatol. 2023 Apr;82(3):256-261. German. doi: 10.1007/s00393-021-01104-1. Epub 2021 Oct 7. Erratum in: Z Rheumatol. 2021 Dec;80(Suppl 2):76. doi: 10.1007/s00393-021-01121-0. PMID: 34618212; PMCID: PMC10076400.
Calprotectin (S100A8/S100A9) detects inflammatory activity in rheumatoid arthritis patients receiving tocilizumab therapy.
Gernert M, Schmalzing M, Tony HP, Strunz PP, Schwaneck EC, Fröhlich M.
Arthritis Res Ther. 2022 Aug 19;24(1):200. doi: 10.1186/s13075-022-02887-7. PMID: 35986420.
Lymphocyte subsets in the peripheral blood are disturbed in systemic sclerosis patients and can be changed by immunosuppressive medication
Gernert M, Tony HP, Schwaneck EC, Gadeholt O, Fröhlich M, Portegys J, Strunz PP, Schmalzing M
Rheumatol Int. 2022 Aug;42(8):1373-1381. doi: 10.1007/s00296-021-05034-8. Epub 2021 Oct 25. PMID: 34694439; PMCID: PMC9287253.
Immunosuppressive Therapy After Autologous Hematopoietic Stem Cell Transplantation in Systemic Sclerosis Patients-High Efficacy of Rituximab
Gernert M, Tony HP, Fröhlich M, Schwaneck EC, Schmalzing M
Front Immunol. 2022 Jan 17;12:817893. doi: 10.3389/fimmu.2021.817893. eCollection 2021. PMID: 35111167
Erratum zu: Apps in der Rheumatologie
Strunz PP, Maire ML, Heusinger T, Hammel L, Gernert M, Schwaneck EC, Callhoff J, Portegys J, Schmalzing M, Tony HP, Froehlich M
Z Rheumatol. 2021 Dec;80(Suppl 2):76. German. doi: 10.1007/s00393-021-01121-0. Erratum for: Z Rheumatol. 2023 Apr;82(3):256-261. doi: 10.1007/s00393-021-01104-1. PMID: 34748079; PMCID: PMC10153493.
High Prevalence of Genital Human Papillomavirus Infection in Patients With Primary Immunodeficiencies.
Gernert M, Kiesel M, Fröhlich M, Renner R, Strunz PP, Portegys J, Tony HP, Schmalzing M, Schwaneck EC.
Front Immunol. 2021 Nov 16;12:789345. doi: 10.3389/fimmu.2021.789345. eCollection 2021. PMID: 34868076
Whole-Body [18F]FDG PET/CT Can Alter Diagnosis in Patients with Suspected Rheumatic Disease.
Fröhlich M, Serfling S, Higuchi T, Pomper MG, Rowe SP, Schmalzing M, Tony HP, Gernert M, Strunz PP, Portegys J, Schwaneck EC, Gadeholt O, Weich A, Buck AK, Bley TA, Guggenberger KV, Werner RA.
Diagnostics (Basel). 2021 Nov 9;11(11):2073. doi: 10.3390/diagnostics11112073.
Clonal expansion of large granular lymphocytes in patients with spondyloarthritis and psoriatic arthritis treated with TNFα inhibitors
Schwaneck EC, Renner R, Tony HP, Weber A, Geissinger E, Gernert M, Fröhlich M, Schmalzing M, Gadeholt O
Rheumatol Int. 2021 Nov;41(11):1979-1986. doi: 10.1007/s00296-021-04872-w. Epub 2021 May 15. PMID: 33991197.
Initial presenting manifestations in 16,486 patients with inborn errors of immunity include infections and noninfectious manifestations.
Thalhammer J, Kindle G, Nieters A, Rusch S, Seppänen MRJ, Fischer A, Grimbacher B, Edgar D, Buckland M, Mahlaoui N, Ehl S; European Society for Immunodeficiencies Registry Working Party.
J Allergy Clin Immunol. 2021 Nov;148(5):1332-1341.e5. doi: 10.1016/j.jaci.2021.04.015. Epub 2021 Apr 23. PMID: 33895260
Immunological Adverse Events After Autologous Hematopoietic Stem Cell Transplantation in Systemic Sclerosis Patients
Strunz PP, Froehlich M, Gernert M, Schwaneck EC, Fleischer A, Pecher AC, Tony HP, Henes JC, Schmalzing M
Front Immunol. 2021 Sep 3;12:723349. doi: 10.3389/fimmu.2021.723349. eCollection 2021. PMID: 34539659
Use of Complementary and Alternative Medicine in Patients with Primary Immunodeficiency: a Multicentric Analysis of 101 Patients
Harasim AS, Krone M, Tony HP, Gawlik M, Witte T, Joos S, Gernert M, Schmalzing M, Morbach H, Schwaneck EC
J Clin Immunol. 2021 Apr;41(3):585-594. doi: 10.1007/s10875-020-00955-8. Epub 2021 Jan 6. PMID: 33403468
Sustained improvement in work outcomes in employed patients with rheumatoid arthritis during 2 years of adalimumab therapy: an observational cohort study.
Behrens F, Tony HP, Koehm M, Schwaneck EC, Gnann H, Greger G, Burkhardt H, Schmalzing M.
Clin Rheumatol. 2020 Sep;39(9):2583-2592. doi: 10.1007/s10067-020-05038-y. Epub 2020 Mar 23. PMID: 32206973
Low B cell counts as risk factor for infectious complications in systemic sclerosis after autologous hematopoietic stem cell transplantation.
Gernert M, Tony HP, Schwaneck EC, Fröhlich M, Schmalzing M.
Arthritis Res Ther. 2020 Aug 8;22(1):183. doi: 10.1186/s13075-020-02255-3. PMID: 32771029
Correction to: Sustained improvement in work outcomes in employed patients with rheumatoid arthritis during 2 years of adalimumab therapy: an observational cohort study.
Behrens F, Tony HP, Koehm M, Schwaneck EC, Gnann H, Greger G, Burkhardt H, Schmalzing M.
Clin Rheumatol. 2020 Aug;39(8):2491. doi: 10.1007/s10067-020-05168-3. PMID: 32474886
Autologous Stem Cell Transplantation in Common Variable Immunodeficiency: A Case of Successful Treatment of Severe Refractory Autoimmune Encephalitis
Froehlich M, Schwaneck EC, Gernert M, Gadeholt O, Strunz PP, Morbach H, Tony HP, Schmalzing M
Front Immunol. 2020 Jun 25;11:1317. doi: 10.3389/fimmu.2020.01317. eCollection 2020. PMID: 32670291
Does concomitant methotrexate confer clinical benefits in patients treated with prior biologic therapy?
Schmalzing M, Behrens F, Schwaneck EC, Koehm M, Greger G, Gnann H, Burkhardt H, Tony HP
Medicine (Baltimore). 2020 May;99(19):e20201. doi: 10.1097/MD.0000000000020201. PMID: 32384515; PMCID: PMC7220320.
Sexual function in German women with systemic sclerosis compared to women with systemic lupus erythematosus and evaluation of a screening test.
Schmalzing M, Nau LF, Gernert M, Froehlich M, Schwaneck EC, Pecher AC, Saur S, Tony HP, Henes M, Henes J.
Clin Exp Rheumatol. 2020 May-Jun;38 Suppl 125(3):59-64. Epub 2020 Apr 14. PMID: 32301433
Osteoporosis therapy in patients with inflammatory rheumatic diseases and osteonecrosis of the jaw
Schwaneck EC, Streit A, Krone M, Hartmann S, Müller-Richter U, Kübler AC, Gadeholt O, Schmalzing M, Tony HP, Brands RC
Z Rheumatol. 2020 Mar;79(2):203-209. English. doi: 10.1007/s00393-019-0606-y. PMID: 30796524.
T cells, natural killer cells, and γδT cells in a large patient cohort with rheumatoid arthritis: influence of age and anti-rheumatic therapy
Schwaneck EC, Renner R, Junker L, Tony HP, Kleinert S, Gernert M, Schmalzing M, Gadeholt O
Scand J Rheumatol. 2020 Jan;49(1):8-12. doi: 10.1080/03009742.2019.1634755. Epub 2019 Sep 26. PMID: 31556339.
Use of a „critical difference“ statistical criterion improves the predictive utility of the Health Assessment Questionnaire-Disability Index score in patients with rheumatoid arthritis.
Behrens F, Koehm M, Schwaneck EC, Schmalzing M, Gnann H, Greger G, Tony HP, Burkhardt H.
BMC Rheumatol. 2019 Dec 10;3:51. doi: 10.1186/s41927-019-0095-2. eCollection 2019. PMID: 31867564
[Recurrent infections of the upper aerodigestive tract in patients with primary immunodeficiency]
Ickrath P, Morbach H, Schwaneck EC, Gehrke T, Scherzad A, Hagen R, Hackenberg S.
HNO. 2019 Nov;67(11):819-824. doi: 10.1007/s00106-019-0683-x. PMID: 31119330
Addition or removal of concomitant methotrexate alters adalimumab effectiveness in rheumatoid arthritis but not psoriatic arthritis.
Behrens F, Koehm M, Schwaneck EC, Schmalzing M, Wittig BM, Gnann H, Greger G, Tony HP, Burkhardt H.
Scand J Rheumatol. 2019 Sep;48(5):375-382. doi: 10.1080/03009742.2019.1600717. Epub 2019 Jul 16. PMID: 31311386
The German National Registry of Primary Immunodeficiencies (2012-2017).
El-Helou SM, Biegner AK, Bode S, Ehl SR, Heeg M, Maccari ME, Ritterbusch H, Speckmann C, Rusch S, Scheible R, Warnatz K, Atschekzei F, Beider R, Ernst D, Gerschmann S, Jablonka A, Mielke G, Schmidt RE, Schürmann G, Sogkas G, Baumann UH, Klemann C, Viemann D, von Bernuth H, Krüger R, Hanitsch LG, Scheibenbogen CM, Wittke K, Albert MH, Eichinger A, Hauck F, Klein C, Rack-Hoch A, Sollinger FM, Avila A, Borte M, Borte S, Fasshauer M, Hauenherm A, Kellner N, Müller AH, Ülzen A, Bader P, Bakhtiar S, Lee JY, Heß U, Schubert R, Wölke S, Zielen S, Ghosh S, Laws HJ, Neubert J, Oommen PT, Hönig M, Schulz A, Steinmann S, Schwarz K, Dückers G, Lamers B, Langemeyer V, Niehues T, Shai S, Graf D, Müglich C, Schmalzing MT, Schwaneck EC, Tony HP, Dirks J, Haase G, Liese JG, Morbach H, Foell D, Hellige A, Wittkowski H, Masjosthusmann K, Mohr M, Geberzahn L, Hedrich CM, Müller C, Rösen-Wolff A, Roesler J, Zimmermann A, Behrends U, Rieber N, Schauer U, Handgretinger R, Holzer U, Henes J, Kanz L, Boesecke C, Rockstroh JK, Schwarze-Zander C, Wasmuth JC, Dilloo D, Hülsmann B, Schönberger S, Schreiber S, Zeuner R, Ankermann T, von Bismarck P, Huppertz HI, Kaiser-Labusch P, Greil J, Jakoby D
Front Immunol. 2019 Jul 19;10:1272. doi: 10.3389/fimmu.2019.01272. eCollection 2019. PMID: 31379802
Power-Doppler perfusion phenotype in RA patients is dependent on anti-citrullinated peptide antibody status, not on rheumatoid factor.
Gadeholt O, Feuchtenberger M, Wech T, Schwaneck EC.
Rheumatol Int. 2019 Jun;39(6):1019-1025. doi: 10.1007/s00296-019-04256-1. Epub 2019 Feb 26. PMID: 30806731
Autologous hematopoietic stem cell transplantation in systemic sclerosis induces long-lasting changes in B cell homeostasis toward an anti-inflammatory B cell cytokine pattern.
Gernert M, Tony HP, Schwaneck EC, Gadeholt O, Schmalzing M.
Arthritis Res Ther. 2019 Apr 29;21(1):106. doi: 10.1186/s13075-019-1889-8. PMID: 31036055
Prevalence and Characteristics of Persistent Clonal T Cell Large Granular Lymphocyte Expansions in Rheumatoid Arthritis: A Comprehensive Analysis of 529 Patients.
Schwaneck EC, Renner R, Junker L, Einsele H, Gadeholt O, Geissinger E, Kleinert S, Gernert M, Tony HP, Schmalzing M.
Arthritis Rheumatol. 2018 Dec;70(12):1914-1922. doi: 10.1002/art.40654. Epub 2018 Oct 30.
Management of anti-HBc-positive patients with rheumatic diseases treated with disease-modifying antirheumatic drugs-a single-center analysis of 2054 patients.
Schwaneck EC, Krone M, Kreissl-Kemmer S, Weißbrich B, Weiss J, Tony HP, Gadeholt O, Schmalzing M, Geier A.
Clin Rheumatol. 2018 Nov;37(11):2963-2970. doi: 10.1007/s10067-018-4295-8. Epub 2018 Sep 20.
Minimal disease activity is a stable measure of therapeutic response in psoriatic arthritis patients receiving treatment with adalimumab.
Behrens F, Koehm M, Schwaneck EC, Schmalzing M, Gnann H, Greger G, Tony HP, Burkhardt H.
Rheumatology (Oxford). 2018 Nov 1;57(11):1938-1946. doi: 10.1093/rheumatology/key203.
Tocilizumab in Large Vessel Vasculitis – Different Routes of Administration
Schmalzing M, Gadeholt O, Gernert M, Tony HP, Schwaneck EC
Open Rheumatol J. 2018 Aug 31;12:152-159. doi: 10.2174/1874312901812010152. PMID: 30258504; PMCID: PMC6128017.
Kinderwunsch bei Lupus erythematodes – eine medizinische Herausforderung
Grän F, Schwaneck EC, Rehn M, Strate A, Goebeler M, Benoit S
J Dtsch Dermatol Ges. 2018 Jul;16(7):913-916. doi: 10.1111/ddg.13577_g. PMID: 29989370.
Pregnancy and lupus erythematosus – a therapeutic challenge
Grän F, Schwaneck EC, Rehn M, Strate A, Goebeler M, Benoit S
J Dtsch Dermatol Ges. 2018 Jul;16(7):913-916. doi: 10.1111/ddg.13577. Epub 2018 Jul 4. PMID: 29972730.
Tocilizumab in Large Vessel Vasculitis – Different Routes of Administration
Schmalzing M, Gadeholt O, Gernert M, Tony HP, Schwaneck EC
Open Rheumatol J, 2018 Aug 31;12:152-159, doi: 10.2174/1874312901812010152.
Kinderwunsch bei Lupus erythematodes – eine medizinische Herausforderung
Grän F, Schwaneck EC, Rehn M, Strate A, Goebeler M, Benoit S
J Dtsch Dermatol Ges, 2018 Jul;16(7):913-916, doi: 10.1111/ddg.13577_g.
Pregnancy and lupus erythematosus – a therapeutic challenge
Grän F, Schwaneck EC, Rehn M, Strate A, Goebeler M, Benoit S
J Dtsch Dermatol Ges, 2018 Jul;16(7):913-916, doi: 10.1111/ddg.13577.
Association of Improvement in Pain With Therapeutic Response as Determined by Individual Improvement Criteria in Patients With Rheumatoid Arthritis
Scharbatke EC, Behrens F, Schmalzing M, Koehm M, Greger G, Gnann H, Burkhardt H, Tony HP
Arthritis Care Res (Hoboken). 2016 Nov;68(11):1607-1615.
Anti-CCP status determines the power Doppler oscillation pattern in rheumatoid arthritis: a prospective study
Gadeholt O, Wech T, Schuh S, Scharbatke EC, Ostermeier E, Tony HP, Schmalzing M
Rheumatol Int. 2016 Dec;36(12):1671-1675.
Does Concomitant Methotrexate with Adalimumab Influence Treatment Outcomes in Patients with Psoriatic Arthritis? Data from a Large Observational Study
Behrens F, Koehm M, Arndt U, Wittig BM, Greger G, Thaçi D, Scharbatke EC, Tony HP, Burkhardt H
J Rheumatol. 2016 Mar;43(3):632-9.
The impact of prior biologic therapy on adalimumab response in patients with rheumatoid arthritis
Feuchtenberger M, Kleinert S, Scharbatke EC, Gnann H, Behrens F, Wittig BM, Greger G, Tony HP
Clin Exp Rheumatol. 2015 May-Jun;33(3):321-9.
Development and Validation of a New Disease Activity Score in 28 Joints–Based Treatment Response Criterion for Rheumatoid Arthritis
Behrens F, Tony HP, Alten R, Kleinert S, Scharbatke EC, Köhm M, Gnann H, Tams J, Greger G, Burkhardt H
Arthritis Care Res. 2013;65:1608–1616.
Vaccination survey in patients with rheumatoid arthritis: a cross-sectional study
Feuchtenberger M, Kleinert S, Schwab S, Roll P, Scharbatke EC, Ostermeier E, Voll RE, Schäfer A, Tony HP
Rheumatol Int. 2011 Feb 15.
Publikationsliste Dr. med. Thorsten Krieger
Four novel mutations in ryanodyn receptor gene (RYR1) found in patients with human stress syndrome and malignant hyperthermia
Krieger T, Steinfath M, Wappler F, Singh S.
Eur J Hum Genet. 2001 May; 9(Supplement 1):382.
Der besondere Fall: Diskrepanz zwischen Myoglobin und Kreatinkinase
Krieger T, Fricke J, Dahlmann N.
Hamburger Ärzteblatt 2002 Oct; 10:469-70.
FK778 in experimental xenotransplantation: a detailed analysis of drug efficacy.
Schrepfer S, Deuse T, Koch-Nolte F, Krieger T, Haddad M, Schafer H, Pelletier MP, Robbins RC, Reichenspurner H.
J Heart Lung Transplant. 2007 Jan; 26(1):70-7.
Dementia and leukoencephalopathy due to lymphomatosis cerebri.
Lewerenz J, Ding X, Matschke J, Schnabel C, Emami P, von Borczyskowski D, Buchert R, Krieger T, de Wit M, Munchau A.
J Neurol Neurosurg Psychiatry. 2007 Jan 8
VP16-mediated expression of human single-chain interleukin-12: highly efficient and suppressible gene expression through adenoviral infection in human colon cancer
Block A, Wulff H, Krieger T, Krüger K, Friesicke M, Thaiss F, Schäfer H, Lohse A (Abstract)
Journal Molecular Therapy; 2007
From mice to men: VP16-mediated highly efficient and tightly regulated gene expression in colorectal cancer
Block A, Wulff H, Cinar S, Krieger T, Krüger K, Friesicke M, Schäfer HJ, Lohse A (Abstract)
Adeno-Tagung, Ulm; 2007 March
Cloning and charakterisation of an adenoviral vector for highly efficient doxycyline-suppressible expression of bioactive human single-chain interleukin 12 in colon cancer
Wulff H, Krieger T, Krüger K, Stahmer I, Thaiss F, Schäfer, Block A
BMC Biotechnology 2007, 7:35 (26 June 2007)
Identification of two new autoantigens in patients with high titeres of antinuklear antibodys using protein macroarray technology.
Hempp C, Haag F, Koch-Nolte F, Krieger T
From Etiopathogeneses to the Prediction of Autoimmune Diseases: Relevance of Autoantibodies. Autoantigenes, Autoantibodies, Autoimmunity 2007 Sep; 5:551-61
Standardization of autoimmune diagnostics in Germany: activities of the German group in the European Autoimmune Standardization Initiative
Sack U, Conrad K, Csernok E, Frank I, Haass M, Krieger T, Seyfarth M, Schlosser U, Schmidt RE, Witte T.
Ann N Y Acad Sci. 2007 Aug;1109:31-6.
Pathophysiologie der Malignen Hyperthermie und des Humanen Stress Syndroms. Nachweis von drei neuen Mutationen im Ryanodinrezeptorgen.
Krieger T
Verlag Dr. Müller ISDN 978-3-8364-7242-5 2008 April
Challenges of automated screening and differentiation of non-organ specific autoantibodies on HEp-2 cells.
Hiemann R, Büttner T, Krieger T, Roggenbuck D, Sack U, Conrad K.
Autoimmun Rev. 2009 Feb 24.
Zöliakie Update, Deamidierte Gliadin-Antikörper verbessern die Diagnostik
Krieger T
MedWelt 2009;60:83-6
Autoantibody detection by indirect immunofluorescence on HEp-2 cells
Sack U, Conrad K, Csernok E, Frank I, Hiepe F, Krieger T, Kromminga A, Landenberg P, Messer G, Witte T, Mierau R; die deutsche EASI-Gruppe (European Autoimmunity Standardization Initiative).
Dtsch Med Wochenschr. 2009 Jun;134(24):1278-82. Epub 2009 Jun 4. Review. German.
CXCR3 mediates renal Th1 and Th17 immune response in murine lupus nephritis.
Steinmetz OM, Turner JE, Paust HJ, Lindner M, Peters A, Heiss K, Velden J, Hopfer H, Fehr S, Krieger T, Meyer-Schwesinger C, Meyer TN, Helmchen U, Mittrücker HW, Stahl RA, Panzer U.
J Immunol. 2009 Oct 1;183(7):4693-704. Epub 2009 Sep 4.
Autoantibody detection using indirect immunofluorescence on HEp-2 cells.
Sack U, Conrad K, Csernok E, Frank I, Hiepe F, Krieger T, Kromminga A, von Landenberg P, Messer G, Witte T, Mierau R; German EASI (European Autoimmunity Standardization Initiative).
Ann N Y Acad Sci. 2009 Sep;1173:166-73.
Deamidated gliadin antibodies faciliate diagnosis in celiac disease
Krieger T, Haag F
From Pathogeneses to therapie of Autoimmune Diseases 2009 Sep. 482-3
Correlates of cognitive dysfunction in multiple sclerosis.
Heesen C, Schulz KH, Fiehler J, Von der Mark U, Otte C, Jung R, Poettgen J, Krieger T, Gold SM.
Brain Behav Immun. 2010 Oct;24(7):1148-55. Epub 2010 May 31.
Interleukin-17-producing T helper cells in autoimmunity.
Hemdan NY, Birkenmeier G, Wichmann G, Abu El-Saad AM, Krieger T, Conrad K, Sack U.
Autoimmun Rev. 2010 Sep;9(11):785-92. Epub 2010 Jul 18.
Endocrine and immune substrates of depressive symptoms and fatigue in multiple sclerosis patients with comorbid major depression.
Gold SM, Krüger S, Ziegler KJ, Krieger T, Schulz KH, Otte C, Heesen C.
J Neurol Neurosurg Psychiatry. 2011 Jul;82(7):814-8. Epub 2011 Feb 4.
Decreased hydrocortisone sensitivity of T cell function in multiple sclerosis-associated major depression.
Fischer A, Otte C, Krieger T, Nicholls RA, Krüger S, Ziegler KJ, Schulz KH, Heesen C, Gold SM.
Psychoneuroendocrinology. 2012 Mar 26.
Dynamic Development of Glucocorticoid Resistance during Autoimmune Neuroinflammation.
Gold SM, Sasidhar MV, Lagishetty V, Spence RD, Umeda E, Ziehn MO, Krieger T, Schulz KH, Heesen C, Hewison M, Voskuhl RR.
J Clin Endocrinol Metab. 2012 Jun 1. [Epub ahead of print]
Automated, semi-automated, and manual analyses of anti-cardiolipin and anti-β2-glycoprotein I antibodies in women with a history of miscarriage.
Gutensohn K, Vossen D, Strate A, Kersten JF, Hofbauer M, Krieger T.
Int J Lab Hematol. 2013 Apr;35(2):150-62. doi: 10.1111/ijlh.12011. Epub 2012 Oct 4.
AComparison of modern analysers for the detection of antiphospholipid antibodies in patients with SLE
Vossen D Hofbauer M, Kersten JK, Krieger T, Peine S, Gutensohn
K J Lab Med 2013
Plasma contact system activation drives anaphylaxis in severe mast cell-mediated allergic reactions.
Sala-Cunill A, Björkqvist J, Senter R, Guilarte M, Cardona V, Labrador M, Nickel KF, Butler L, Luengo O, Kumar P, Labberton L, Long A, Di Gennaro A, Kenne E, Jämsä A, Krieger T, Schlüter H, Fuchs T, Flohr S, Hassiepen U, Cumin F, McCrae K, Maas C, Stavrou E, Renné T.
J Allergy Clin Immunol. 2015 Apr;135(4):1031-43.e6. doi: 10.1016/j.jaci.2014.07.057. Epub 2014 Sep 18.
Hyperferritinemia in adult HLH: the best what we have, so far.
Machowicz R, Kröger N, Krieger T, Zborowska H, RejowskiS, Górka M, Wiktor-Jedrzejczak W
Blood Apr. 2015 125/10/1548-52
Utility of Marked Hyperferritinemia in Diagnosis Hemophagocytic Syndrom in Adults
Machowicz T, Kröger N, Krieger T, Zbowska H, Rejowski S. Gorka M. Jedrzejczak W
Pediadric Blood & Cancer Nev. 2015 62:132
Neutrophil Extracellular Traps Contain Selected Antigens of Anti-Neutrophil Cytoplasmic Antibodies.
Panda R, Krieger T, Hopf L, Renné T, Haag F, Röber N, Conrad K, Csernok E, Fuchs TA.
Front Immunol. 2017 Apr 13;8:439. doi: 10.3389/fimmu.2017.00439. eCollection 2017.
BCL11B mutations in patients affected by a neurodevelopmental disorder with reduced type 2 innate lymphoid cells.
Lessel D, Gehbauer C, Bramswig NC, Schluth-Bolard C, Venkataramanappa S, van Gassen KLI, Hempel M, Haack TB, Baresic A, Genetti CA, Funari MFA, Lessel I, Kuhlmann L, Simon R, Liu P, Denecke J, Kuechler A, de Kruijff I, Shoukier M, Lek M, Mullen T, Lüdecke HJ, Lerario AM, Kobbe R, Krieger T, Demeer B, Lebrun M, Keren B, Nava C, Buratti J, Afenjar A, Shinawi M, Guillen Sacoto MJ, Gauthier J, Hamdan FF, Laberge AM, Campeau PM, Louie RJ, Cathey SS, Prinz I, Jorge AAL, Terhal PA, Lenhard B, Wieczorek D, Strom TM, Agrawal PB, Britsch S, Tolosa E, Kubisch C.
Brain. 2018 Aug 1;141(8):2299-2311. doi: 10.1093/brain/awy173.
Off-label application of intravenous immunoglobulin (IVIG) for treatment of Cogan’s syndrome during pregnancy.
Scherg F, Haag F, Krieger T.
BMJ Case Rep. 2019 Oct 10;12(10). pii: e227917. doi: 10.1136/bcr-2018-227917.
